Objectives: this study was carried out to evaluate the prevalence of sensory-neural hearing loss (SNHL) among telephone operators and its risk factors specially the effect of headset noise on the hearing ability of the telephone operators. Methods: a cross-sectional study was carried out on 58 telephone operators and 30 administration staff workers at Mansoura Telecommunications Company in Egypt. All participants were interviewed using a structured questionnaire including personal, medical and occupational history; and underwent an audiometric examination. Audiometric evaluation was done to evaluate hearing threshold levels (HTLs) for air and bone conduction for both right and left ears of all participants. Background noise was measured both at telephone operator and administration departments. Results: telephone operators had significantly higher prevalence of acoustic shock symptoms and decreased hearing sensitivity (46.6% and 37.9 %, respectively) compared to the controls (3.3% and 13.3%, respectively). Telephone operator had significantly higher HTLs compared to the controls, for air and bone conduction for both ears at lower and higher frequencies without the characteristic notch of noise induced hearing loss (NIHL). Among telephone operators, headset users had higher HTLs compared to headset non users, for air and bone conduction at the higher frequencies for both ears but more obviously in the left ear. There were 26 (44.8%) cases of SNHL among the telephone operators versus no cases among the controls; all of them were bilateral in distribution. Among other studied factors, only headset use (OR= 5.2, 95%CI = 1.7-16.1) and age (OR= 1.1, 95%CI = 1.0-1.2) were significant risk factors for developing SNHL among telephone operators. Conclusion: telephone operators are exposed to sudden repeated unexpected loud sounds due to headset use which could affect their hearing ability.
Objective: Perform clinical and histopathological evaluations of gingival hyperplasia after kidney transplantation in patients receiving either cyclosporine (CsA) or tacrolimus (TAC). Subjects and Methods: A sample of 54 male renal transplant patients who have undergone immunosuppressive regimen (CsA=28 and TAC=26) were examined in respect to demographic, pharmacologic and periodontal variables. Gingival overgrowth (GO) was assessed by using gingival enlargement index. In addition gingival biopsies were examined histopathologically with Hematoxylin and eosin (H&E) stain and Immunohistochemistry using caspase 3 expression and histomorphometric Analyses. Furthermore the serum level of matrix metalloproteinase (MMP2) was assessed in the two groups. Data were analyzed statistically using the Statistical Package for Social Sciences (SPSS). Results: Considering gingival enlargement, there was a statistically significant difference between (CsA) and (TAC) group's index with higher mean in (CsA) group versus (TAC) group. Considering the gingival bleeding index, there was a statistically significant difference between (CsA) and (TAC) groups with higher mean in (CsA) group versus (TAC) group and regarding serum (MMP2) level, there was statistically significant difference between (CsA) and (TAC) groups with lower mean in (CsA) group versus (TAC) group. Histopathologically, the degree of tacrolimusinfluenced gingival enlargement was lesser in comparison to (CsA) group. Conclusions: (CsA) induced a greater degree of gingival enlargement than (TAC) as shown clinically and histolopathologically but the serum level of (MMP2) was higher in (TAC) group than in the (CsA) group. (MMP2) may have a role in the mechanism of gingival enlargement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.